Very Rare Cancer Consortium Tumor Board Meeting

July 16, 2020, 4:00pm – 6:00pm | New York Genome Center

Please join us for the Very Rare Cancer Consortium Tumor Board Meeting. This new initiative aims to bring cancer researchers across New York to the table to discuss compelling rare cancer cases presented by physicians and scientists from the New York Genome Center’s partner institutions. Click here to learn more about the Very Rare Cancer Consortium.

Thursday, July 16, 2020
4pm – 6pm 


Case Conference 

This will be a VIRTUAL meeting via Zoom.
Please note registration is required.



Jing Chen, MD 
Pediatric Hematology-Oncology
Hackensack Meridian Health
Hackensack University Medical Center
“12 months old MLL-rearranged ALL relapse with lineage switch to AML with extensive extramedullary disease”


Gabriel Robbins, MD
Assistant Professor of Pediatrics
Hassenfeld Children’s Hospital at
NYU Langone Health
Division of Pediatric Hematology/Oncology

“Adolescent with Ph-like B-ALL and hyperdiploidy, with overexpression of both CRLF2 and EPOR”


Jaclyn Rosenzweig, MD
Pediatric Hematology-Oncology Fellow
Memorial Sloan Kettering Cancer Center
NewYork Presbyterian/Weill Cornell
Medical Center
“10 month old with FUS-ERG fusion infant B-ALL” 


Neal Shukla, MD
Pediatric Oncologist
Memorial Sloan Kettering Cancer Center
“21 year old with extramedullary relapse of mixed phenotype acute leukemia”  


Lauren Weintraub, MD 
Director of Brain Tumor Program
Albany Medical College
22 year old female isolated extramedullary AML relapse post-HSCT”


Maria Luisa Sulis, MD, MS
Chief, Pediatric Hematologic
Malignancies Service
Memorial Sloan Kettering Cancer Center
“Three teenagers with CML and an unusual BCR-ABL mutation of unknown significance”